Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Altshuler David
Relationship:   EVP, Chief Scientific...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   25,813    

Indirect Shares

  0      
Direct Value   $11,436,450    

Indirect Value

  $0      
Total Shares   25,813      
Total Value   $11,436,450      


Vertex Pharmaceuticals Inc
 $11,436,450 Vertex Pharmaceuticals Inc
 $11,436,450
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Chief Scientific... 2024-05-15 25,813 2014-07-31 0    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2016-02-02 4 A $0.01 $144 D/D 14,416 89,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-02-13 4 AS $87.68 $561,415 D/D (6,403) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-04-28 4 OE $63.14 $473,550 D/D 7,500 113,511 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-04-28 4 AS $120.00 $900,000 D/D (7,500) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-05-15 4 AS $114.37 $20,701 D/D (181) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-06-05 4 AS $130.00 $975,000 D/D (7,500) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-06-05 4 OE $72.14 $541,050 D/D 7,500 113,511 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-07-19 4 AS $161.00 $4,665,619 D/D (28,979) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-07-19 4 OE $81.54 $2,448,338 D/D 28,979 134,990 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-08-31 4 OE $91.05 $163,526 D/D 1,796 107,807 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-08-31 4 AS $160.00 $287,360 D/D (1,796) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2017-11-15 4 AS $147.71 $45,630 D/D (306) 106,011 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-01-16 4 AS $155.77 $8,830,755 D/D (56,250) 49,761 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-01-22 4 OE $91.05 $163,526 D/D 1,796 51,557 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-01-22 4 AS $160.00 $287,360 D/D (1,796) 49,761 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-02-02 4 AS $165.24 $298,330 D/D (1,796) 49,761 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-02-02 4 OE $91.05 $163,526 D/D 1,796 51,557 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-02-06 4 A $0.00 $0 D/D 26,641 76,402 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-02-12 4 AS $149.23 $965,671 D/D (6,403) 69,999 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-05-15 4 AS $155.78 $15,266 D/D (98) 69,999 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-06-29 4 AS $161.57 $7,313,596 D/D (44,331) 39,113 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-06-29 4 OE $86.52 $1,171,397 D/D 13,445 83,444 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-07-16 4 OE $131.89 $3,082,929 D/D 23,375 62,488 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-07-16 4 AS $182.00 $4,254,250 D/D (23,375) 39,113 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2018-08-02 4 AS $174.59 $313,564 D/D (1,796) 39,113 0 -

  157  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed